Chronic Spontaneous Urticaria

Also known as: Spontaneous Urticaria, Chronic / Chronic idiopathic urticaria / Chronic idiopathic urticaria (disorder)

DrugDrug NameDrug Description
DB11591BilastineA peripheral histamine H1-antagonist used to treat seasonal allergic rhinitis and chronic spontaneous urticaria.
DrugDrug NamePhaseStatusCount
DB06612Mepolizumab0Active Not Recruiting1
DB11856Ligelizumab1Terminated1
DB00043Omalizumab1Recruiting1
DB18136Briquilimab1 / 2Recruiting1
DB12023Benralizumab2Terminated1
DB09061Cannabidiol2Unknown Status1
DB12159Dupilumab2Completed1
DB11856Ligelizumab2Completed3
DB16728Lirentelimab2Active Not Recruiting1
DB00043Omalizumab2Completed2
DB00043Omalizumab2Recruiting1
DB17709Rilzabrutinib2Active Not Recruiting1
DB15090Tezepelumab2Completed1
DB15227Tirabrutinib2Withdrawn1
DB00041Aldesleukin2 / 3Not Yet Recruiting1
DB00043Omalizumab2 / 3Completed1
DB12159Dupilumab3Recruiting2
DB06282Levocetirizine3Completed1
DB11856Ligelizumab3Completed3
DB11856Ligelizumab3Terminated1
DB00043Omalizumab3Completed6
DB00043Omalizumab3Not Yet Recruiting1
DB00043Omalizumab3Recruiting1
DB16852Remibrutinib3Active Not Recruiting1
DB16852Remibrutinib3Completed3
DB16852Remibrutinib3Recruiting3
DB06282Levocetirizine4Recruiting1
DB00455Loratadine4Not Yet Recruiting1
DB00043Omalizumab4Completed1
DB00043Omalizumab4Recruiting1
DB00302Tranexamic acid4Recruiting1
DB11856LigelizumabNot AvailableNo Longer Available1
DB16852RemibrutinibNot AvailableAvailable1